Bowel Research UK — grant history
Latest income
£1.6m
Grants listed (FY2025)
7
Listed grants total
£439k
Accounts grants total
£494k
listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts
What changed: FY2024 → FY2025
| Change | Grantee | FY2024 | FY2025 |
|---|---|---|---|
| new | University of Birmingham | — | £111k |
| new | University of Edinburgh | — | £111k |
| new | University of Liverpool | — | £62k |
| new | Kings College London | — | £60k |
| new | Imperial College London | — | £48k |
| new | University Hospital of Wales, Cardiff | — | £43k |
| new | Golden Jubilee National Hospital, Glasgow | — | £4k |
| not listed | University of Oxford | £114k | — |
| not listed | University of Manchester | £50k | — |
| not listed | University of York | £50k | — |
| not listed | Leeds Beckett University | £50k | — |
| not listed | Alder Hey Children’s NHS Foundation Trust | £47k | — |
| not listed | University of Leeds | £47k | — |
| not listed | Sheffield Teaching Hospitals NHS Foundation Trust | £32k | — |
| not listed | NHS Glasgow and Clyde | £30k | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University of Birmingham | FY2025 | £111k | Realising the potential of FMT as the ultimate dysbiosis remedy; a unifying analysis of FMT composition |
| University of Edinburgh | FY2025 | £111k | Dysbiosis driven delays to intestinal regeneration and repair |
| University of Liverpool | FY2025 | £62k | Evaluating the role of faecal microbiome in assessing response to neoadjuvant treatment, surveillance and nutritional prehabilitation in colorectal cancer |
| Kings College London | FY2025 | £60k | Does high-fibre dietary advice improve symptoms in people with chronic constipation? A randomised controlled feasibility trial of a digital intervention. |
| Imperial College London | FY2025 | £48k | CApsulised faecal microbiota Transplant to Capture response to tHerapy in Inflammatory Bowel Disease (The CATCH-IBD study) |
| University Hospital of Wales, Cardiff | FY2025 | £43k | The role of a new tool for LARS assessment LARS iCAT |
| Golden Jubilee National Hospital, Glasgow | FY2025 | £4k | Weight loss and reduction in colorectal adenoma recurrence: a PPI work |
| University of Oxford | FY2024 | £114k | Investigating the role of periostin-innate immune cell neighbourhoods (PIN's) in colorectal cancer progression |
| University of Manchester | FY2024 | £50k | Targeting the mucus matrix to prevent peritoneal metastasis in mucinous lower GI cancers |
| University of York | FY2024 | £50k | Exploiting sodium transport as a novel biomarker of aggression in bowel cancer |
| Leeds Beckett University | FY2024 | £50k | Optimising bowel cancer screening and surveillance for people with cystic fibrosis: a qualitative study to identify and understand clinician and patient challenges and needs and ways to address these |
| Alder Hey Children’s NHS Foundation Trust | FY2024 | £47k | Babies with Enterocolitis - A study of faecal Calprotectin in Hirschsprung’s disease (the BEACH study) |
| University of Leeds | FY2024 | £47k | Remote Monitoring for Preoperative Risk Assessment for Major Colorectal Surgery |
| Sheffield Teaching Hospitals NHS Foundation Trust | FY2024 | £32k | Does female anal intercourse cause damage to the anus and anal sphincter? |
| NHS Glasgow and Clyde | FY2024 | £30k | Tackling important (but hard to fund) questions in bowel disease: assessing the feasibility of decision architecture randomisation trials in routine care |
| University of Oxford | FY2024 | £26k | Re-evaluating colorectal cancer diagnostic markers and therapies in the context of tumoral acidosis: towards molecularly-stratified treatments that consider in-vivo chemical selection pressures |
| University of Nottingham | FY2024 | £17k | The Impact of Ethnicity of Surgical Outcomes in Patients with Inflammatory Bowel Disease |
| Brunel University | FY2024 | £3k | Functional analysis of two novel colorectal cancer risk loci on chromosome 11:POLD3 and CHRDL2 |
| University of the Highlands and Islands | FY2024 | £2k | STAMP: Self-help to actively manage parastomal hernial |
| University of Hull | FY2024 | £2k | Targeting ADAM10 as a novel strategy for radiotherapy enhancement in hypoxic colorectal cancer |
| University of Liverpool | FY2023 | £118k | Development of novel therapies for Hirschsprung’s Disease |
| Sheffield Hallam | FY2023 | £117k | Illuminating the tissue barriers leading to treatment resistance and recurrence |
| University of Oxford | FY2023 | £94k | Investigating interactions between colorectal cancer subclones and fibroblasts |
| NHS Greater Glasgow and Clyde | FY2023 | £57k | Peri-Operative Surgical Care Optimisation for Patients requiring Emergency Surgery (PERI-SCOPES) |
| Imperial College London | FY2023 | £50k | The impact of ethnicity on inflammatory bowel disease: phenotype and response to treatment |
| University of Southampton | FY2023 | £50k | Developing NOTUM as a target for immunotherapy of bowel cancer |
| Roger Williams Institute of Hepatology | FY2023 | £49k | Decoding extracellular matrix signatures that drive malignancy in colon cancer |
| Queen Mary University of London | FY2023 | £48k | Epigenetic reprogramming of monocytes in Crohn’s disease: a pilot study of a multiomic approach |
| University of Southampton | FY2023 | £42k | The ‘empty pelvis syndrome’ — defining and reducing morbidity from a major cause of complications after complex pelvic cancer surgery |
| University of Manchester | FY2023 | £32k | Clinical, immune and microbial characterisation of genital Crohn's disease |
| Salford Royal NHS Foundation Trust | FY2023 | £28k | National Open Abdomen Audit (NOAA) |
| Countess of Chester Hospital | FY2023 | £20k | DAMASCUS II study: Diverticulitis Management A Snapshot Collaborative Study |
| East Lancashire Hospitals NHS Trust | FY2023 | £5k | REview of Sigmoid VoLVulus ManagEment: RESOLVE Study |
| Marshall Wave | FY2022 | £108k | Research Grant |
| Parastomal hernia and shared decision making | FY2022 | £84k | Research Grant |
| Percutaneous infracoccygeal Botulinum toxin injection for treatment of dyssynergic defaecation | FY2022 | £75k | Research Grant |
| Development of a blood test to find early signs of colorectal cancer in people with inflammatory bowel disease | FY2022 | £75k | Research Grant |
| New strategies for improving radiotherapy response in bowel cancer | FY2022 | £75k | Research Grant |
| Treatment pathway to improve bowel control after bowel resection for colorectal cancer | FY2022 | £50k | Research Grant |
| Utility variations in two genes that increase the risk of bowel cancer | FY2022 | £50k | Research Grant |
| Identify new strategies to prevent immune cells supporting in colorectal liver metastasis | FY2022 | £50k | Research Grant |
| Effectiveness of an Acceptance and Commitment Therapy based psychological intervention on reducing psychological distress in those diagnosed with Gastro-intestinal Dysmotility | FY2022 | £50k | Research Grant |
| how immune dysfunction impacts ulverative colitis using human mini colons | FY2022 | £50k | Research Grant |
| Causes of rare and severe complications of Paediatric Inflammatory Bowel Disease | FY2022 | Unverified read£49k | Research Grant |
| Investigating the role of bacteria-infecting viruses in inflammatory bowel disease | FY2022 | £49k | Research Grant |
| IBD Self management | FY2022 | £46k | Research Grant |
| Decision-making in complex pelvic exentreration surgery for patients with locally advanced or recurrent rectal cancer | FY2022 | £40k | Research Grant |
| collaboration to improve management of patients with rare retrorectal tumors | FY2022 | Unverified read£18k | Research Grant |
| International of patients with rare | FY2022 | £16k | Research Grant |
| Laparoscopy or Antibiotics for Managing Appendicitus | FY2022 | £15k | Research Grant |
| of Motility-MIR in the assessment of Feorgut Neuromuscular children with Paediatric Intestinal Pseudo-Obstruction | FY2022 | £4k | Research Grant |
Write-backs & cancellations
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| Grants withdrawn | FY2022 | −£63k | Withdrawal |